Rentokil Initial PLC is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has seen hedge fund buying and some positive analyst ratings, the technical indicators are neutral, options data suggests bearish sentiment, and recent price action shows a downward trend. For a long-term investor, it may be better to wait for clearer positive signals or a more attractive entry point.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 58.581, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 30.577 with resistance at 32.125 and support at 29.029.

Hedge fund buying has increased by 181.06% in the last quarter. Analysts like BofA and Morgan Stanley have upgraded the stock, citing growth potential in the North American pest control market and untapped residential opportunities.
The stock is down 0.38% in regular trading and 2.06% in pre-market. Deutsche Bank and Rothschild & Co have downgraded the stock, citing underperformance in the pest control category and potential pressure on near-term estimates. Options data shows bearish sentiment with a high put-call ratio.
Rentokil Initial reported FY 2025 revenue of $6.91 billion, reflecting a modest 4.4% year-over-year growth. GAAP EPS was $0.11. While revenue growth is positive, it is not particularly strong, and there are no standout financial metrics to suggest a compelling buy case.
Recent analyst ratings are mixed. RBC Capital raised its price target to 540 GBp and maintained an Outperform rating. However, Deutsche Bank downgraded the stock to Hold, and Rothschild & Co downgraded it to Sell. Morgan Stanley and BofA are more optimistic, with Morgan Stanley upgrading the stock to Overweight and BofA adding it to its 'Europe 1 list' of top ideas.